Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Correlation of immunohistochemical expression of p53 with unamplified chromosome 17 polysomy in invasive breast carcinoma.

Krishnamurti U, Zarineh A, Atem FD, Silverman JF.

Appl Immunohistochem Mol Morphol. 2011 Jan;19(1):28-32. doi: 10.1097/PAI.0b013e3181e9bb6f.

PMID:
20823770
2.

Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma.

Krishnamurti U, Hammers JL, Atem FD, Storto PD, Silverman JF.

Mod Pathol. 2009 Aug;22(8):1044-8. doi: 10.1038/modpathol.2009.61. Epub 2009 Apr 24.

3.

Chromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplification.

Orsaria M, Khelifa S, Buza N, Kamath A, Hui P.

J Clin Pathol. 2013 Dec;66(12):1070-5. doi: 10.1136/jclinpath-2013-201506. Epub 2013 Aug 1.

PMID:
23908451
4.

[Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].

Zeng X, Liang ZY, Wu SF, Zhou WX, Gao J, Liu TH.

Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):584-8. Chinese.

PMID:
17134563
5.

Genetic alterations and protein expression of HER2 and chromosome 17 polysomy in breast cancer.

Zhu X, Lu Y, Lu H, Yang W, Tu X, Cai X, Zhou X.

Hum Pathol. 2011 Oct;42(10):1499-504. doi: 10.1016/j.humpath.2010.04.023. Epub 2011 Jun 14.

PMID:
21676436
6.

Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.

Vanden Bempt I, Van Loo P, Drijkoningen M, Neven P, Smeets A, Christiaens MR, Paridaens R, De Wolf-Peeters C.

J Clin Oncol. 2008 Oct 20;26(30):4869-74. doi: 10.1200/JCO.2007.13.4296. Epub 2008 Sep 15.

PMID:
18794552
7.
8.

Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.

Simonetti S, Russo R, Ciancia G, Altieri V, De Rosa G, Insabato L.

Int J Surg Pathol. 2009 Jun;17(3):198-205. doi: 10.1177/1066896909333415.

PMID:
19443884
9.

Status of HER2 amplification, polysomy 17 and histopathological features of 425 Pakistani breast cancer patients.

Moatter T, Aban M, Iqbal W, Azam I, Pervaiz A, Siddiqui F, Murad F, Pervez S.

Asian Pac J Cancer Prev. 2011;12(11):3069-73.

10.

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.

Salido M, Tusquets I, Corominas JM, Suarez M, Espinet B, Corzo C, Bellet M, Fabregat X, Serrano S, Solé F.

Breast Cancer Res. 2005;7(2):R267-73. Epub 2005 Jan 26.

11.

[Clinicopathologic significance of chromosome 17 polysomy in breast cancer].

Lü YL, Zhong M, Liu L, Wei LX, Zhao P.

Zhonghua Bing Li Xue Za Zhi. 2008 Feb;37(2):88-91. Chinese.

PMID:
18681318
12.

Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy.

Tse CH, Hwang HC, Goldstein LC, Kandalaft PL, Wiley JC, Kussick SJ, Gown AM.

J Clin Oncol. 2011 Nov 1;29(31):4168-74. doi: 10.1200/JCO.2011.36.0107. Epub 2011 Sep 26.

PMID:
21947821
13.

Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.

Liang Z, Zeng X, Gao J, Wu S, Wang P, Shi X, Zhang J, Liu T.

BMC Cancer. 2008 Dec 6;8:363. doi: 10.1186/1471-2407-8-363.

14.

Effect of high copy number of HER2 associated with polysomy 17 on HER2 protein expression in invasive breast carcinoma.

Shah SS, Wang Y, Tull J, Zhang S.

Diagn Mol Pathol. 2009 Mar;18(1):30-3. doi: 10.1097/PDM.0b013e31817c1af8.

PMID:
19214111
15.
16.

Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.

Nassar A, Khoor A, Radhakrishnan R, Radhakrishnan A, Cohen C.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6254-61. eCollection 2014.

17.

Assessment of p53 and HER-2/neu genes status and protein products in oral squamous cell carcinomas.

Stoicănescu D, Andreescu N, Belengeanu A, Meszaros N, Cornianu M.

Rom J Morphol Embryol. 2013;54(4):1107-13.

18.

Evaluation of numeric alterations of chromosomes 1 and 17 by in situ hybridization in invasive breast carcinoma with clinicopathologic parameters.

Nakopoulou L, Giannopoulou I, Trafalis D, Gakiopoulou H, Keramopoulos A, Davaris P.

Appl Immunohistochem Mol Morphol. 2002 Mar;10(1):20-8.

PMID:
11893031
19.

Impact of polysomy 17 on HER2 testing of invasive breast cancer patients.

Liu Y, Ma L, Liu D, Yang Z, Yang C, Hu Z, Chen W, Yang Z, Chen S, Zhang Z.

Int J Clin Exp Pathol. 2013 Dec 15;7(1):163-73. eCollection 2014.

20.

Centromere 17 copy number alteration: negative prognostic factor in invasive breast cancer?

Petroni S, Addati T, Mattioli E, Caponio MA, Quero C, Rubini V, Giotta F, Simone G.

Arch Pathol Lab Med. 2012 Sep;136(9):993-1000. doi: 10.5858/arpa.2011-0327-OA.

PMID:
22938586

Supplemental Content

Support Center